Tissue Culture & Biorepository for Cell Lines and Biofluids Shared ResourcePublications
Artym, V. V., Y. Zhang, F. Seillier-Moiseiwitsch, K. M. Yamada, and S. C. Mueller. 2006. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 66:3034-3043.
Ayyad SB, Israel E, El Setouhy M, Nasr GR, Mohamed MK, Loffredo CA. 2006. Evaluation of Papanicolaou stain for studying micronuclei in buccal cells under field conditions. Acta Cytol 50(4):398-402.
Bowden, E. T., E. Onikoyi, R. Slack, A. Myoui, T. Yoneda, K. M. Yamada, and S. C. Mueller. 2006. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp.Cell Res 312:1240-1253.
Brew CT, Aronchik I, Hsu JC, Sheen JH, Dickson RB, Bjeldanes LF, Firestone GL. 2006. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells. Int J Cancer 118(4):857-868.
Creighton CJ, Cordero KE, Larios JM, Miller RS, Johnson MD, Chinnaiyan AM, Lippman ME, Rae JM. Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors. Genome Biol 2006; 7(4):R28.
Di Giovanni S, Knights CD, Rao M, Yakovlev A, Beers J, Catania J, Avantaggiati ML, Faden AI. 2006. The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. EMBO J 25(17):4084-4096.
Fan, S., Q. Meng, K. Auborn, T. Carter, and E. M. Rosen. 2006. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer 94:407-426.
Han, W., T. Zhang, H. Yu, J. G. Foulke, and C. K. Tang. 2006. Hypophosphorylation of Residue Y1045 Leads to Defective Downregulation of EGFRvIII. Cancer Biol Ther. Oct 26;5(10) [Epub ahead of print]
Kang, H. J., H. J. Kim, J. K. Rih, T. L. Mattson, K. W. Kim, C. H. Cho, J. S. Isaacs, and I. Bae. 2006. BRCA1 plays a role in the hypoxic response by regulating HIF-1alpha stability and by modulating vascular endothelial growth factor expression. J Biol Chem 281:13047-13056.
Katiyar, P., Y. Ma, S. Fan, R. G. Pestell, P. A. Furth, and E. M. Rosen. 2006. Regulation of progesterone receptor signaling by BRCA1 in mammary cancer. Nucl.Recept.Signal 4:e006.
Kiyomiya K, Lee MS, Tseng IC, Zuo H, Barndt RJ, Johnson MD, Dickson RB, Lin CY. 2006. Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells. Am J Physiol Cell Physiol 291(1):C40-C49.
Knights, C. D., J. Catania, S. Di Giovanni, S. Muratoglu, R. Perez, A. Swartzbeck, A. A. Quong, X. Zhang, T. Beerman, R. G. Pestell, and M. L. Avantaggiati. 2006. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol 173:533-544.
Ma, Y., R. Q. Yuan, S. Fan, C. Hu, I. D. Goldberg, J. J. Laterra, and E. M. Rosen. 2006. Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum. Anticancer Drugs 17:733-751.
Ma, Y., P. Katiyar, L. P. Jones, S. Fan, Y. Zhang, P. A. Furth, and E. M. Rosen. 2006. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. Mol Endocrinol. 20:14-34.
Mani, A., A. S. Oh, E. T. Bowden, T. Lahusen, K. L. Lorick, A. M. Weissman, R. Schlegel, A. Wellstein, and A. T. Riegel. 2006. E6AP Mediates Regulated Proteasomal Degradation of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 in Immortalized Cells. Cancer Res 66:8680-8686.
Mewani, R. R., S. Tian, B. Li, M. T. Danner, T. D. Carr, S. Lee, A. Rahman, U. N. Kasid, M. Jung, A. Dritschilo, and P. C. Gokhale. 2006. Gene expression profile by inhibiting Raf-1 protein kinase in breast cancer cells. Int J Mol Med 17:457-463.
Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10(6):515-527.
Rae JM, Johnson MD, Cordero KE, Scheys JO, Larios JM, Gottardis MM, Pienta KJ, Lippman ME. 2006. GREB1 is a novel androgen-regulated gene required for prostate cancer growth. Prostate 66(8):886-894.
Regadera J, Blanquez MJ, Gonzalez-Peramato P, Nistal M, Miller JC, Tirado OM, Notario V. 2006. PCPH expression is an early event in the development of testicular germ cell tumors. Int J Oncol 28(3):595-604.
Riggins RB, Thomas KS, Ta HQ, Wen J, Davis RJ, Schuh NR, Donelan SS, Owen KA, Gibson MA, Shupnik MA, Silva CM, Parsons SJ, Clarke R, Bouton AH. 2006. Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. Cancer Res 66(14):7007-7015.
Rodriguez O, Fricke S, Chien C, Dettin L, VanMeter J, Shapiro E, Dai HN, Casimiro M, Ileva L, Dagata J, Johnson MD, Lisanti MP, Koretsky A, Albanese C. 2006. Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI. Cell Cycle 5(1):113-119.
Sakamaki T, Casimiro MC, Ju X, Quong AA, Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, Wang C, Byers S, Nicholson R, Link T, Shemluck M, Yang J, Fricke ST, Novikoff PM, Papanikolaou A, Arnold A, Albanese C, Pestell R. 2006. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 26(14):5449-5469.
Shah, S., M. N. Islam, S. Dakshanamurthy, I. Rizvi, M. Rao, R. Herrell, G. Zinser, M. Valrance, A. Aranda, D. Moras, A. Norman, J. Welsh, and S. W. Byers. 2006. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol Cell 21:799-809.
Shah, R., B. Rahaman, C.K. Hurley, P.E. Posch. 2006. Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms. Human Genetics, 119:61-74.
Shah, R., C.K. Hurley, P.E. Posch. 2006. A molecular mechanism for the differential regulation of TGF-beta1 expression due to the common SNP -509C-T (c.-1347C>T). Human Genetics 120:461-9.
Steiner, N., C.K. Hurley. 2006. KIR3DL3 allelic diversity: Six new alleles exhibit both conservative and non-conservative substitutions. Tissue Antigens 67:277-283.
Tassi, E., R. T. Henke, E. T. Bowden, M. R. Swift, D. P. Kodack, A. H. Kuo, A. Maitra, and A. Wellstein. 2006. Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon. Cancer Res 66:1191-1198.
Tian, S., R. R. Mewani, D. Kumar, B. Li, M. T. Danner, I. Ahmad, A. Rahman, V. Notario, A. Dritschilo, U. N. Kasid, and P. C. Gokhale. 2006. Interaction and stabilization of X-linked inhibitor of apoptosis by Raf-1 protein kinase. Int J Oncol 29:861-867.
Tirado OM, Mateo-Lozano S, Villar J, Dettin LE, Llort A, Gallego S, Ban J, Kovar H, Notario V. 2006. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing’s sarcoma cells. Cancer Res 66(20):9937-9947.
Toretsky, J. A., V. Erkizan, A. Levenson, O. D. Abaan, J. D. Parvin, T. P. Cripe, A. M. Rice, S. B. Lee, and A. Uren. 2006. Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A. Cancer Res 66:5574-5581.
Vandenbussche, C., S. Dakshananmurthy, P. Posch, C.K. Hurley. 2006. A single polymorphism disrupts the killer Ig-like receptor (KIR) 2DL2/2DL3 D1 domain. J. Immunol. 177:5347-57.
Xie, B., E. Tassi, M. R. Swift, K. McDonnell, E. T. Bowden, S. Wang, Y. Ueda, Y. Tomita, A. T. Riegel, and A. Wellstein. 2006. Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGF-binding protein by phage display. J Biol Chem 281:1137-1144.
Xie, Z., H. Yuan, Y. Yin, X. Zeng, R. Bai, and R. I. Glazer. 2006. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases. BMC Cancer 6:77.
Zhang, C., D. Chakravarty, I. Sakabe, R. R. Mewani, H. E. Boudreau, D. Kumar, I. Ahmad, and U. N. Kasid. 2006. Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther. 13:947-955.